A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
Condition(s):Prader-Willi SyndromeLast Updated:September 14, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Prader-Willi SyndromeLast Updated:September 14, 2023Active, not recruiting
Condition(s):Hyperphagia in Prader-Willi SyndromeLast Updated:March 5, 2024Recruiting
Condition(s):Prader-Willi Syndrome; ObesityLast Updated:September 22, 2014Completed
Condition(s):Prader-Willi Syndrome; Growth Hormone DeficiencyLast Updated:September 24, 2021Completed
Condition(s):Prader-Willi SyndromeLast Updated:June 1, 2023Completed
Condition(s):Prader-Willi SyndromeLast Updated:March 27, 2020Completed
Condition(s):Prader-Willi SyndromeLast Updated:June 22, 2023Terminated
Condition(s):Prader-Willi SyndromeLast Updated:March 21, 2023Recruiting
Condition(s):Prader-Willi SyndromeLast Updated:September 1, 2016Completed
Condition(s):Prader-Willi SyndromeLast Updated:March 5, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.